XWELL (XWEL) investor relations material

Executive summary

• Revenue for Q2 2026 was $7.1M, down 7% year-over-year, mainly due to the cessation of HyperPointe operations and a slight decrease in Naples Wax revenue.

• Operating loss for Q2 2026 was $2.1M, an improvement from a $2.7M loss in Q2 2025, driven by lower cost of sales.

• Net loss attributable to common stockholders for Q2 2026 was $2.2M ($0.26 per share), compared to $3.0M ($0.56 per share) in Q2 2025.

• The company completed a $28.3M private placement in February 2026 and used $9M to repurchase preferred stock, convertible notes, and warrants.

• A strategic sale of airport-based operations for $13M was announced in July 2026, expected to close in Q4 2026.

Financial highlights

• Q2 2026 revenue: $7.1M (down 7% YoY); six-month revenue: $13.8M (down 6% YoY).

• Q2 2026 gross profit: $2.9M (up from $1.8M YoY); six-month gross profit: $5.3M (up from $3.1M YoY).

• Q2 2026 operating loss: $2.1M (improved from $2.7M YoY); six-month operating loss: $7.5M (vs. $5.9M YoY).

• Q2 2026 net loss attributable to common stockholders: $2.2M ($0.26/share); six-month net loss: $13.4M ($1.69/share).

• Cash and cash equivalents at June 30, 2026: $11.8M; working capital surplus: $8.5M.

Outlook and guidance

• Management expects sufficient liquidity for at least the next twelve months, supported by recent capital raises and cost controls.

• The sale of airport-based operations is expected to streamline the business and focus on non-airport wellness activities.